Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension

doi:10.4254/wjh.v9.i5.270

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9294)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

507

WORD

226

HTML

3456

Figures (1-2)

289

Tables (1-3)

251

Sum=4729

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

578

Download

1210

Sum=1788

Publishing Process of This Article

Item

Count

Browse

1047

Download

1730

Sum=2777

Feb 18, 2017 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Hepatol. Feb 18, 2017; 9(5): 270-277
Published online Feb 18, 2017. doi: 10.4254/wjh.v9.i5.270

Full Size Figure Download Figure

Figure 2 General linear model comparing Pre (baseline), chronic (carvedilol at 3 mo) and post simvastatin haemodynamic parameters with respect to time in carvedilol responders and non-responders. HR: Heart rate; MAP: Mean arterial pressure; FHVP: Free hepatic venous pressure; WHPG: Wedged hepatic venous pressure gradient; HVPG: Hepatic venous pressure gradient.

Citation: Wani ZA, Mohapatra S, Khan AA, Mohapatra A, Yatoo GN. Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension. World J Hepatol 2017; 9(5): 270-277
URL: https://www.wjgnet.com/1948-5182/full/v9/i5/270.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i5.270